COVID-19 vaccine effectiveness among South Asians in Canada
Open Access
- 1 August 2024
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 4 (8) , e0003490
Abstract
We evaluated the effectiveness of COVID-19 vaccines among South Asians living in Ontario, Canada compared to non-South Asians and compared the odds of symptomatic COVID-19 infection and related hospitalizations and deaths among non-vaccinated South Asians and non-South Asians. This was a test negative design study conducted in Ontario, Canada between December 14, 2020 and November 15, 2021. All eligible individuals >18 years with symptoms of COVID-19 were subdivided by ethnicity (South Asian vs other) and vaccination status (vaccinated versus not). The primary outcome was vaccine effectiveness as defined by COVID-19 infections, hospitalizations, and deaths, and secondary outcome was the odds of COVID-19 infections, hospitalizations, and death comparing non-vaccinated South Asians to non-vaccinated non-South Asians. 883,155 individuals were included. Among South Asians, two doses of COVID-19 vaccine prevented 93.8% (95% CI 93.2, 94.4) of COVID-19 infections and 97.5% (95% CI 95.2, 98.6) of hospitalizations and deaths. Among non-South Asians, vaccines prevented 86.6% (CI 86.3, 86.9) of COVID-19 infections and 93.1% (CI 92.2, 93.8) of hospitalizations and deaths. Non-vaccinated South Asians had higher odds of symptomatic SARS-CoV-2 infection compared to non-vaccinated non-South Asians (OR 2.35, 95% CI 2.3, 2.4), regardless of their immigration status. COVID-19 vaccines are effective in preventing infections, hospitalizations and deaths among South Asians living in Canada. The observation that non-vaccinated South Asians have higher odds of symptomatic COVID-19 infection warrants further investigation.Keywords
Funding Information
- Institute for Clinical Evaluative Sciences
- Public Health Agency of Canada (2122-HQ-000058)
- Ontario Health Data Platform
- Canada Research Chairs (CRC-2017-00024)
This publication has 30 references indexed in Scilit:
- Sex, Racial, and Ethnic Representation in COVID-19 Clinical TrialsJAMA Internal Medicine, 2023
- Efficacy of COVID-19 vaccines by race and ethnicityPublic Health, 2022
- HLA variation and antigen presentation in COVID-19 and SARS-CoV-2 infectionCurrent Opinion in Immunology, 2022
- COVID-19 Vaccine Decision-making Factors in Racial and Ethnic Minority Communities in Los Angeles, CaliforniaJAMA Network Open, 2021
- COVID-19 vaccine acceptance in South Asia: a multi-country studyInternational Journal of Infectious Diseases, 2021
- Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01eClinicalMedicine, 2021
- Racial and Ethnic Health Disparities Related to COVID-19JAMA, 2021
- Ethnicity and clinical outcomes in COVID-19: A systematic review and meta-analysiseClinicalMedicine, 2020
- Plasma ACE2 and risk of death or cardiometabolic diseases: a case-cohort analysisThe Lancet, 2020
- Sharpening the global focus on ethnicity and race in the time of COVID-19The Lancet, 2020